Stanford University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).

1,744 total trials 264 currently recruiting 1122 completed early-phase tilt top decile by trial count

Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.

Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.

Top-decile sponsor footprint

Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,744 total, page 22 of 35

COMPLETED NA

The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study

NCT02256306

COMPLETED NA

A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease

NCT02100722

COMPLETED Phase 4

Intranasal Bevacizumab for HHT-Related Epistaxis

NCT02389959

COMPLETED NA

Thermal Compression Device for Maintenance of Perioperative Normothermia

NCT02155400

COMPLETED NA

Building Better Caregivers: Development and Evaluation

NCT02205671

COMPLETED

Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma

NCT01926990

COMPLETED

Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis

NCT02224898

COMPLETED Phase 1

Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer

NCT02184533

COMPLETED Phase 1

Hyaluronidase Effect on Infusion Set Life

NCT02199028

COMPLETED Phase 2

Dakin's Solution in Preventing Radiation Dermatitis in Patients With Breast Cancer Undergoing Radiation Therapy

NCT02203565

COMPLETED NA

Hybrid Closed-Loop Hotel Studies With Medtronic PID Controller

NCT02280863

COMPLETED NA

Magnesium L-Threonate for the Enhancement of Learning and Memory in People With Dementia

NCT02210286

COMPLETED NA

Assessment of an Automatic Closed-loop Insulin Delivery System

NCT02366767

COMPLETED NA

Virtual Advisors for Physical Activity Promotion in Underserved Communities

NCT02111213

COMPLETED

A Biosensor for Tracking Seizures: Linking a Wrist Accelerometer to an Online Epilepsy Diary

NCT02177877

COMPLETED Phase 2

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

NCT03125629

COMPLETED Phase 4

The Effect of Intravenous Acetaminophen on Post-Operative Pain After Craniotomy

NCT03445390

COMPLETED

Cerebral Oxygenation and Autoregulation in Preterm Infants

NCT02147769

TERMINATED Phase 1

Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer

NCT01943188

TERMINATED NA

Brain Connectivity and Mindfulness Training in Youth With Bipolar Disorder Not Otherwise Specified (NOS)

NCT02435225

COMPLETED

Risk Factors for Acquired Cardiovascular Disease in Adults With Congenital Heart Disease

NCT02433990

COMPLETED Phase 2

The Peanut Oral Immunotherapy Study: Safety, Efficacy and Discovery

NCT02103270

TERMINATED NA

Placebo-Controlled Therapeutic Trial for the Prevention of Lymphedema

NCT01893879

COMPLETED NA

Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise Protocol

NCT02047643

COMPLETED NA

Cardiovascular Health in Postpartum Women Diagnosed With Excessive Gestational Weight Gain

NCT02142452

COMPLETED NA

Levocarnitine in Treating Patients With Vismodegib-Associated Muscle Spasms

NCT01893892

COMPLETED NA

Transcranial Magnetic Stimulation (TMS) for CRPS

NCT02067273

COMPLETED NA

A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan

NCT01616797

COMPLETED NA

Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II)

NCT01945112

COMPLETED

A Pilot Study of "Stanford Proxy Test for Delirium" (S-PTD)

NCT03954769

COMPLETED

Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study

NCT01551576

TERMINATED Phase 1

Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT01904643

TERMINATED NA

Trial of a Nationwide Cognitive-Affective Remediation Training Intervention in Depression

NCT02075190

COMPLETED NA

Ultrasound Elastography in Imaging Patients With Thyroid Nodules

NCT03174925

COMPLETED NA

Parent-Based Prevention (PBP) for Parents With Eating Disorders

NCT04254068

COMPLETED

Evaluation of Pain Measurement Device

NCT02036567

COMPLETED NA

Sustainable Methods, Algorithms, and Research Tools for Delivering Optimal Care Study

NCT02037438

COMPLETED NA

Applications of Realtime Functional Magnetic Resonance Imaging (fMRI )

NCT01111617

COMPLETED NA

Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

NCT01908166

COMPLETED NA

Pivotal Response Treatment Package for Young Children With Autism

NCT02037022

COMPLETED Phase 2

The Role of Vasopressin in the Social Deficits of Autism

NCT01962870

COMPLETED

Neurocognitive Effects and Tolerability of Efavirenz in Aging HIV-infected Individuals ("SHAC Neuro Study")

NCT01985399

TERMINATED Phase 1

Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer

NCT01928030

COMPLETED NA

Temperature Study in Cesarean Section

NCT01249014

COMPLETED NA

Feasibility of Combining Family and Cognitive Therapy to Prevent Chronic Anorexia

NCT02054364

COMPLETED NA

Clavicle Splint for Pain Reduction After Posterior Cervicothoracic Surgery

NCT01977690

COMPLETED NA

Neural Signatures of Parkinson's Disease

NCT01990313

COMPLETED Phase 1

Effects of Mifepristone on Biomarkers of Metabolic Function and Neuropsychological Performance Among Middle-Aged and Older Individuals

NCT01988610

COMPLETED NA

Physical Activity Incentives

NCT03037658

COMPLETED NA

Improving Self Management Skills of Older Adults With Diabetes

NCT01943357

← Previous Page 22 of 35 Next →

Phase Distribution

PhaseTrial count
Phase 1 193
Phase 2 209
Phase 3 51
Phase 4 86

What is open in the Stanford University pipeline

264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).

Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).

Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.